The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Biogen Idec Inc  (BIIB) Trade Now »     Rate BIIB  -  Discuss BIIB  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
77.0%
Top:
66.5%
Rate BIIB:



BIIB Analysis & Videos »


BIIB: Bull or Bear?

David Fried's Buyback Premium Portfolio: Mid-Month Update Graphic_rating_buy BIIB
+99.89%
in 543 days
By  David Fried   (+20.95%  risk: conservative)  12/09/10 1 comment


Biogen Idec Looks Bullish on Earnings Guidance Graphic_rating_buy BIIB
+149.87%
in 685 days
By  Wade Hansen   (+6.59%  risk: conservative)  07/20/10 2 comments


FDA Calendar Updates: Amgen, Bayer, Biogen, Noveko, Peplin, Transdel Graphic_rating_buy BIIB
Mikerun
73%
+193.28%
in 1062 days
By  Mike Havrilla   (+1.04%  risk: moderate)  07/08/09 5 comments


Get free stock alert for BIIB:
Your Email Address:


FDA Decision Calendar: Pain Drug Delays Likely Graphic_rating_buy BIIB
Mikerun
73%
-12.22%
in 148 days
(closed on 07/08/09)
By  Mike Havrilla   (+1.04%  risk: moderate)  02/10/09 23 comments


Drug and health care stocks: The right prescription for 2009 Graphic_rating_buy BIIB
+178.94%
in 1246 days
By  Steven Halpern   (+9.32%  risk: moderate)  01/05/09 1 comment


Biotech no longer a safe haven: Elan (ELN) falls on hard times Graphic_rating_sell BIIB
-183.97%
in 1269 days
By  Jamie Dlugosch   (+43.14%  risk: conservative)  12/12/08 1 comment


Biogen Reports Another PML Case in Tysabri Patient Graphic_rating_buy BIIB
Mikerun
73%
+29.15%
in 102 days
(closed on 02/10/09)
By  Mike Havrilla   (+1.04%  risk: moderate)  10/30/08 5 comments


Biogen Reports Another PML Case in Tysabri Patient Graphic_rating_buy BIIB
Mikerun
73%
+0.00%
in 3 hours
(closed on 10/30/08)
By  Mike Havrilla   (+1.04%  risk: moderate)  10/29/08 15 comments


Get free stock alert for BIIB:
Your Email Address:


Biotech Blues: Four Stocks on Sale with Hope Graphic_rating_buy BIIB
Mikerun
73%
-3.42%
in 4 days
(closed on 10/29/08)
By  Mike Havrilla   (+1.04%  risk: moderate)  10/25/08 5 comments


Who's Next in the Biotech Buyout Frenzy? Graphic_rating_buy BIIB
Mikerun
73%
-6.30%
in 12 days
(closed on 10/25/08)
By  Mike Havrilla   (+1.04%  risk: moderate)  10/13/08 2 comments


An Even Pfatter Yield at Pfizer Graphic_rating_buy BIIB
Mikerun
73%
+0.00%
in 1 hours
(closed on 10/13/08)
By  Mike Havrilla   (+1.04%  risk: moderate)  10/12/08 7 comments


Clarity on Tysabri Makes Elan and Biogen a Buy Graphic_rating_buy BIIB
Rxlogo
50%
+172.34%
in 1366 days
By  Mike Havrilla   (-14.46%  risk: conservative)  09/06/08 4 comments


Clarity on Tysabri Makes Elan and Biogen a Buy Graphic_rating_buy BIIB
Mikerun
73%
-9.49%
in 35 days
(closed on 10/11/08)
By  Mike Havrilla   (+1.04%  risk: moderate)  09/06/08 5 comments


Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity Graphic_rating_buy BIIB
+161.11%
in 1392 days
By  A. Reza Saadat   (+69.83%  risk: conservative)  08/11/08 2 comments


Still bullish on this guy. Graphic_rating_buy BIIB
Condor
41%
+89.04%
in 1409 days
By  Doodahdoodoo   (-7.40%  risk: aggressive)  07/25/08 4 comments





People Bullish on BIIB

David Fried
Tracked Blogger
N/A
about 1 year ago

Wade Hansen
Tracked Blogger
N/A
about 1 year ago

sdepatie
Analyst
N/A
over 2 years ago

Mikerun
Mike Havrilla
Principal
73%
over 2 years ago

henmeng
Analyst
N/A
over 2 years ago


People Bearish on BIIB

hotpikjim
Analyst
N/A
over 2 years ago

Jamie Dlugosch
Tracked Blogger
78%
over 3 years ago

webmom
Analyst
59%
over 3 years ago

mlgeorge
Analyst
N/A
over 4 years ago

Andrew C
Analyst
 6 %
over 4 years ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on BIIB


Discussion Wall + Add  

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   4 replies

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   29 replies


More Resources

Graphic_arrow1 About Biogen Idec Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch